SIMBA SLEEP LIMITED

Company number 09703422 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: SIMBA SLEEP LIMITED


1. Financial Health Score: C (Guarded / Indeterminate)

Grade explanation:
The company demonstrates positive “administrative vital signs”: it is active, not in insolvency proceedings, approximately ten years old, and its filings are not overdue. These are equivalent to a patient being conscious, responsive, and keeping regular check-up appointments. However, the data provided contains no turnover, profit, asset, liability, or cash figures. Without those core clinical measurements, it is impossible to assess profitability, liquidity, or solvency. The grade of C therefore reflects structural stability but financial indeterminacy—like a patient who is alive and attending appointments, but whose blood work and imaging results are not yet available.


2. Key Vital Signs

Vital Sign Reading Interpretation
Corporate status Active The company is registered and trading; not in liquidation, administration, or receivership.
Filing compliance Accounts and confirmation statement not overdue Regulatory “check-ups” are current. Timely filing is good administrative hygiene, though it does not by itself indicate profitability.
Company age Incorporated 27 July 2015; accounts made up to 31 December 2025 Roughly ten years of trading history. An established business rather than a new venture.
Account classification Group Consolidated accounts covering more than one entity. This is like examining several interconnected body systems; it adds complexity and requires careful review of intercompany relationships.
Share capital £14 Very low nominal subscribed capital. A thin financial skeleton; the business likely depends on other funding sources or retained earnings, but this cannot be confirmed without the balance sheet.
Sector Manufacture of mattresses (SIC 31030) Consumer discretionary manufacturing. Typically working-capital intensive (inventory, receivables) and sensitive to household spending cycles.
Governance Four current directors A board is in place to provide oversight and decision-making.
Persons with significant control PSC statement present, no control details provided Ownership transparency is only partially visible; the extent and nature of significant control are not detailed in the data supplied.

Vital signs that cannot be measured from the data provided:
Revenue trends, gross and net profit margins, current ratio (liquidity), net assets (solvency), gearing, and operating cash flow. These are the equivalent of blood pressure, cholesterol, and heart-rate readings—essential for a full diagnosis, but absent here.


3. Diagnosis

The company is administratively stable but clinically unexamined based on the information available. Being active and up to date with filings suggests the business is being maintained properly at a corporate level. However, the absence of the underlying profit and loss account and balance sheet means no conclusion can be drawn about whether the company is generating profit, holding sufficient cash, or meeting its obligations as they fall due.

The low share capital and group structure are features that warrant closer inspection of the actual accounts. A thin capital base is not inherently a sign of illness, but it does mean the business may have less internal cushion to absorb shocks. Because it operates in mattress manufacturing—a sector that typically carries inventory and extends credit to retailers—working-capital management is likely to be a critical factor in its financial wellbeing.


4. Prognosis

Guarded.
The company is not in formal insolvency, and its filings are current, which are positive indicators. However, the prognosis cannot be confirmed without reviewing the financial statements. If the accounts show consistent profitability, positive net assets, and healthy cash generation, the outlook could be revised upward. If they reveal trading losses, negative net current assets, or declining cash reserves, the company could face liquidity pressure despite remaining administratively compliant.


5. Recommendations

  1. Obtain the full filed annual accounts for the year ended 31 December 2025, together with prior-year comparatives, from Companies House or the company’s records.
  2. Review the balance sheet for cash balances, inventory levels, trade debtors, trade creditors, and net assets to assess short-term resilience.
  3. Review the profit and loss account for revenue trends, gross margins, and operating profit to determine whether the core mattress manufacturing business is profitable.
  4. Calculate key ratios, including the current ratio (current assets ÷ current liabilities), gross profit margin, and net profit margin, to benchmark against sector norms.
  5. Examine the cash flow statement to verify that reported profits are converting into actual cash, which is particularly important for a manufacturer holding stock.
  6. Assess the group structure and any intercompany balances, guarantees, or funding arrangements that could affect the parent company’s risk exposure.
  7. Maintain filing compliance to avoid penalties and preserve good standing at Companies House.
  8. Model downside scenarios for consumer spending, given that mattress demand is discretionary and sensitive to wider economic conditions.

Perspective: Financial Health Diagnostician · Model: nvidia/nemotron-3.5-super-vl:free · Generated 13 November 2026